VREOF Overview

Acquisition Announcement: Vireo Growth Inc. plans to acquire approximately $2.6 million in senior secured convertible notes from Medicine Man Technologies (Schwazze) for about $1.6 million in subordinate voting shares, representing a significant discount.

Transaction Details: Upon completion, Vireo will hold around 89% of Schwazze's outstanding notes, with the transaction subject to customary conditions and regulatory approvals.

Company Overview: Vireo, founded in 2014, focuses on the medical cannabis industry, emphasizing a disciplined and strategic approach to market operations and growth.

Forward-Looking Statements: The press release includes forward-looking information regarding financial outlooks and potential risks, cautioning readers against placing undue reliance on these projections.

Acquisition Details: Vireo Growth (VREO) has agreed to acquire 17 retail locations from PharmaCann Inc. in Colorado for $49 million in an all-stock deal, increasing its store count in the state to 41.

Payment Structure: The acquisition will be financed through subordinate voting shares, with adjustments for inventory and liabilities, along with the assumption of certain debts.

Operational Transition: A subsidiary of Vireo will manage the newly acquired dispensaries during the transition period, pending approval from state and local regulators.

Timeline for Closure: The transaction is anticipated to be finalized in the first half of 2026.

Financial Results Announcement: Vireo Growth Inc. will release its financial results for the third fiscal quarter on November 12, 2025, before the market opens.

Conference Call Details: A conference call to discuss the results will be held on the same day at 8:30 a.m. ET, with dial-in options provided for participants.

Company Overview: Founded in 2014, Vireo Growth is a medical cannabis company focused on strategic execution and local market engagement while leveraging a national portfolio.

Commitment to Stakeholders: Vireo emphasizes a long-term approach, prioritizing action and commitment to customers, employees, shareholders, and communities.

Ayr Wellness Developments: Ayr Wellness is advancing its debt restructuring while launching its first indoor cultivation facility in Florida, which will produce premium cannabis and create around 100 jobs.

Vireo Growth Acquisition: Vireo Growth has acquired $91 million in senior secured convertible notes from Schwazze for $62 million, aiming to gain control over Schwazze's assets and reshape its operations.

Tilray's Expansion: Tilray has expanded into Panama through a joint venture, receiving a medical cannabis license to cultivate, manufacture, and distribute cannabis, enhancing its global presence.

Enveric and Algernon Updates: Enveric Biosciences has strengthened its intellectual property with a new patent for neuroplastogenic compounds, while Algernon Pharmaceuticals has rebranded to Algernon Health, focusing on Alzheimer's diagnostics and establishing neuroimaging clinics.

Acquisition Announcement: Vireo Growth Inc. has agreed to acquire approximately 86% of the senior secured convertible notes of Medicine Man Technologies Inc. for about $62 million, payable in subordinate voting shares at a price of $0.54 per share.

Transaction Details: The acquisition is expected to close later this month, pending customary conditions and necessary approvals.

Company Background: Vireo Growth Inc., founded in 2014, focuses on building a disciplined and strategically aligned platform in the medical cannabis industry, emphasizing local market strength and a commitment to stakeholders.

Forward-Looking Statements: The press release includes forward-looking information that may involve risks and uncertainties, cautioning readers against placing undue reliance on these projections.

Company Update: Vireo Growth Inc. has confirmed, at the request of CIRO, that it is unaware of any material changes in operations that would explain the recent increase in market activity.

Company Overview: Founded in 2014, Vireo Growth Inc. is a medical cannabis pioneer focused on building a disciplined and execution-oriented platform while maintaining a commitment to its stakeholders and communities.